Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Lobelane Inhibits Methamphetamine-Evoked Dopamine Release via Inhibition of the Vesicular Monoamine Transporter-2
Journal of Pharmacology and Experimental Therapeutics, 10/28/09
Nickell JR et al. – The current results reveal that lobelane, a selective VMAT2 inhibitor, inhibits methamphetamine–evoked DA release and is a promising lead for the development of a pharmacotherapeutic for methamphetamine abuse.
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Opiate-induced hypernociception and chemokine receptors
Neuropharmacology, 11/10/09
Ketorolac But Not Morphine Exerts Inflammatory and Metabolic Effects in Synovial Membrane After Knee Arthroscopy: A Double-Blind Randomized Prospective Study Using the Microdialysis Technique
Regional Anesthesia and Pain Medicine, 11/04/09
Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Current Drug Targets, 11/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


